BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21576352)

  • 1. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors.
    Segatto O; Anastasi S; Alemà S
    J Cell Sci; 2011 Jun; 124(Pt 11):1785-93. PubMed ID: 21576352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity.
    Anastasi S; Baietti MF; Frosi Y; Alemà S; Segatto O
    Oncogene; 2007 Dec; 26(57):7833-46. PubMed ID: 17599051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback inhibitors of the epidermal growth factor receptor signaling pathways.
    Gotoh N
    Int J Biochem Cell Biol; 2009 Mar; 41(3):511-5. PubMed ID: 18762271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
    Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
    Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
    Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics.
    Anastasi S; Lamberti D; Alemà S; Segatto O
    Semin Cell Dev Biol; 2016 Feb; 50():115-24. PubMed ID: 26456277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRIG1 expression in colorectal cancer.
    Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
    Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.
    Iejima D; Minegishi Y; Takenaka K; Siswanto A; Watanabe M; Huang L; Watanabe T; Tanaka F; Kuroda M; Gotoh N
    Oncogene; 2010 May; 29(21):3087-99. PubMed ID: 20228838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
    Curto M; Cole BK; Lallemand D; Liu CH; McClatchey AI
    J Cell Biol; 2007 Jun; 177(5):893-903. PubMed ID: 17548515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal regulated kinase signalling pathway.
    Orton RJ; Sturm OE; Gormand A; Wolch W; Gilbert DR
    IET Syst Biol; 2008 Jul; 2(4):173-83. PubMed ID: 18681747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
    Ouyang X; Gulliford T; Huang G; Epstein RJ
    J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
    Wu Y; Chen Z; Ullrich A
    Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.